申请人:Mitsubishi Kasei Corporation
公开号:US04977151A1
公开(公告)日:1990-12-11
Ethanone oximes represented by the following general formula: ##STR1## wherein R.sup.1 represents a cycloalkyl group, aryl group, aralkyl group, aryloxy group, aralkyloxy group, arylthio group or aryl sulfonyl group, those groups being optionally substituted with a substituent selected from an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms and a halogen atom, piperidino group, piperazino group, 4-alkyl substituted piperazino group, imidazolyl group 4-alkyl substituted imidazolyl group or substituted amino group, R.sup.2 represents a hydrogen atom or an alkoxy group having 1 to 3 carbon atoms, and R.sup.3 represents a piperidino group, piperazino group or 4-alkyl substituted piperazino group, or R.sup.1 and R.sup.2 together with a phenyl group to which they are attached may form a phenothiazin-2-yl group, N-acetyl-phenothiazin-2-yl group, thianthren-2-yl group, dibenzothiophen-3-yl group, dibenzofuran-3-yl group or a group of the formula: ##STR2## wherein R.sup.4 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, or a pharmaceutically acceptable acid addition salts thereof are disclosed. They are a potent antiulcer agent.
以下为Ethanone oximes的通用式:##STR1## 其中R.sup.1代表环烷基、芳基、芳基烷基、芳氧基、芳基氧烷基、芳硫基或芳基磺酰基,这些基团可以选用一个取代基,所述取代基选自具有1至3个碳原子的烷基、具有1至3个碳原子的烷氧基和卤素原子、哌啶基、哌嗪基、4-烷基取代哌嗪基、咪唑基、4-烷基取代咪唑基或取代氨基,R.sup.2代表氢原子或具有1至3个碳原子的烷氧基,R.sup.3代表哌啶基、哌嗪基或4-烷基取代哌嗪基,或者R.sup.1和R.sup.2与它们附着的苯基一起可以形成苯并噻唑-2-基、N-乙酰基苯并噻唑-2-基、噻芘-2-基、二苯并噻吩-3-基、二苯并呋喃-3-基或式的基团:##STR2## 其中R.sup.4代表氢原子或具有1至3个碳原子的烷基,或其药学上可接受的酸盐。它们是一种有效的抗溃疡剂。